🧪 UPDATED DAILY FROM CLINICALTRIALS.GOVSynced today

Find Clinical Trials for Your Rare Disease

12123+ recruiting trials across all rare diseases. Filter by phase, location, and condition.

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Showing 20 of 12123 recruiting trials

NARecruitingNCT06734052

Computer-guided Action Planning to Support Physical Activity (CAPPA) for Employees with Chronic Knee Symptoms

👨‍⚕️ Daniel Pinto, PhD, Marquette University📍 1 site📅 Started Aug 2024View details ↗
Phase 2RecruitingNCT06104228

129 Xenon MRI as a Biomarker for Diagnosis and Response to Therapy in Pulmonary Arterial Hypertension (PAH)

👨‍⚕️ Fawaz Alenezi, MD, Duke Univeristy📍 1 site📅 Started Aug 2024View details ↗
Phase 1, PHASE2RecruitingNCT06189157

MB-CART19.1 in Refractory SLE

👨‍⚕️ Georg Schett, Prof. Dr., University Clinical Erlangen, Medical Clinic 3📍 3 sites📅 Started Aug 2024View details ↗
RecruitingNCT06558786

Registry for Esophageal and Gastroesophageal Junction Cancer

👨‍⚕️ Daniela Molena, MD, Memorial Sloan Kettering Cancer Center📍 1 site📅 Started Aug 2024View details ↗
NARecruitingNCT06831318

Community Health Worker-Led Transition Support for Persons Living With Dementia and Caregivers

👨‍⚕️ Jung Kwak, PhD, University of Texas at Austin📍 1 site📅 Started Aug 2024View details ↗
RecruitingNCT06971042

Early Diagnosis of ARDS in Mechanically Ventilated Patient Using LUS Score in Comparison With CT

👨‍⚕️ Roaa Elshamy, MSc, Tanta University📍 1 site📅 Started Aug 2024View details ↗
RecruitingNCT06495866

Ultrasound Assessment of Entheseal Sites in Patients with Seronegative Spondyloarthropathy with or Without Fibromyalgia

👨‍⚕️ Ahmed R Al-Agamy, MD, Sohag University📍 1 site📅 Started Aug 2024View details ↗
Phase 2RecruitingNCT06530550

PI3K Inhibitors for the Treatment of Relapsed/Refractory Indolent T/NK-cell Lymphomas

👨‍⚕️ Shuhua Yi, Doctor, Institute of Hematology & Blood Diseases Hospital, China📍 1 site📅 Started Aug 2024View details ↗
Phase 2RecruitingNCT06530576

Thalidomide for the Symptomatic Large Granular Lymphocytic Leukemia

👨‍⚕️ Shuhua Yi, Doctor, Institute of Hematology & Blood Diseases Hospital, China📍 1 site📅 Started Aug 2024View details ↗
Phase 2RecruitingNCT06388031

ICI Rechallenge for Advanced NSCLC With Long-Term Response to First-Line ICI

👨‍⚕️ Minjiang Chen, MD., Peking Union Medical College Hospital📍 1 site📅 Started Aug 2024View details ↗
RecruitingNCT06550427

Early Assessment of Lymphoma Treatment Response Using Phased Variant Analysis With Next-Generation Sequencing

👨‍⚕️ Tai-Chung Huang, Ph.D, National Taiwan University Hospital📍 1 site📅 Started Aug 2024View details ↗
Phase 1, PHASE2RecruitingNCT06788470

Safety and Efficacy of Umbilical Cord-derived Mesenchymal Stem Cell(MSC) Transplantation in the Treatment of Bronchopulmonary Dysplasia(BPD) in Premature Infants

🏥 The Children's Hospital of Zhejiang University School of Medicine📍 1 site📅 Started Aug 2024View details ↗
NARecruitingNCT06212492

Effects on Biotrauma of NMBAs and PP Association During ARDS

👨‍⚕️ François Cremieux, AP-HM📍 1 site📅 Started Aug 2024View details ↗
EARLY_Phase 1RecruitingNCT06479863

Efficacy and Safety of Pozelimab and Cemdisiran Combination Therapy in Patients With Sporadic Inclusion Body Myositis

👨‍⚕️ Yessar Hussain, MD, Austin Neuromuscular Center📍 2 sites📅 Started Aug 2024View details ↗
Phase 1RecruitingNCT06313593

A Study to Evaluate the Safety, Tolerability of INCB160058 in Participants With Myeloproliferative Neoplasms

👨‍⚕️ Incyte Medical, Incyte Corporation📍 31 sites📅 Started Aug 2024View details ↗
Phase 2RecruitingNCT06576973

Adbelimumab Combined With Chemotherapy and Apatinib in Patients With Resectable Esophageal Squamous Cell Carcinoma

👨‍⚕️ Wang, 2nd Affiliated Hospital, School of Medicine, Zhejiang University📍 1 site📅 Started Aug 2024View details ↗
Phase 2RecruitingNCT06311981

Carbon Ion Radiotherapy for Locally Advanced Lung Cancer in Elderly Patients

👨‍⚕️ Jingfang Mao, PHD, Shanghai Proton and Heavy Ion Center📍 1 site📅 Started Aug 2024View details ↗
NARecruitingNCT06474520

Efficacy and Safety of Calculus Bovis Sativus (CBS) for Idiopathic Inflammatory Demyelinating Disease (CBSinIIDD)

👨‍⚕️ Wei Wang, MD, Tongji Hospital📍 1 site📅 Started Aug 2024View details ↗
RecruitingNCT07515508

Multimodal Phenotyping In Patients Referred With Acute Cardiac faiLurE

🏥 University Heart Center Freiburg - Bad Krozingen📍 4 sites📅 Started Aug 2024View details ↗
Phase 2RecruitingNCT06598722

BCL-2 Inhibitors Combined with the HyperCVAD Regimen for Newly Diagnosed T-lymphoblastic Leukemia/lymphoma.

🏥 Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine📍 1 site📅 Started Aug 2024View details ↗
← PreviousPage 257 of 607Next →

Get alerts when new trials open

Create a free account to follow conditions and receive trial notifications.

Create free account →